Kovack Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-1,903
Closed -$279K 523
2019
Q1
$279K Sell
1,903
-290
-13% -$42K 0.07% 306
2018
Q4
$293K Sell
2,193
-3,330
-60% -$546K 0.09% 267
2018
Q3
$1.05M Buy
5,523
+14
+0.3% +$2.57K 0.27% 96
2018
Q2
$918K Sell
5,509
-455
-8% -$73K 0.26% 102
2018
Q1
$1M Sell
5,964
-999
-14% -$168K 0.25% 93
2017
Q4
$1.14M Buy
6,963
+637
+10% +$114K 0.29% 78
2017
Q3
$1.3M Buy
6,326
+310
+5% +$72.1K 0.43% 50
2017
Q2
$1.46M Buy
6,016
+1,052
+21% +$247K 0.46% 43
2017
Q1
$1.19M Buy
4,964
+529
+12% +$123K 0.46% 44
2016
Q4
$931K Buy
4,435
+2,475
+126% +$513K 0.44% 42
2016
Q3
$451K Sell
1,960
-440
-18% -$108K 0.22% 112
2016
Q2
$555K Buy
2,400
+312
+15% +$71.9K 0.29% 83
2016
Q1
$560K Sell
2,088
-212
-9% -$60.7K 0.35% 81
2015
Q4
$719K Sell
2,300
-198
-8% -$58.9K 0.47% 55
2015
Q3
$679K Buy
2,498
+262
+12% +$80.5K 0.47% 53
2015
Q2
$679K Buy
2,236
+173
+8% +$51.6K 0.48% 48
2015
Q1
$614K Buy
2,063
+1,089
+112% +$310K 0.52% 44
2014
Q4
$251K Buy
+974
New +$243K 0.26% 106

Other funds holding AGN

Kovack Advisors's AGN Position: Q2 2019 in Review

Kovack Advisors sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 1,903 shares — an estimated $279K sold.

Kovack Advisors first reported a position in AGN in Q4 2014 and held it in 18 quarters. The position peaked at $1.46M in Q2 2017. 970 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Kovack Advisors reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Kovack Advisors sold 1,903 Allergan plc shares in Q2 2019, an estimated $279K.
  • Kovack Advisors first reported a position in Allergan plc in Q4 2014 and held it in 18 quarters.
  • Kovack Advisors's Allergan plc position peaked at $1.46M in Q2 2017.
  • 970 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Kovack Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.